Surface Oncology, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Surface Oncology, Inc. quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q2 2023.
  • Surface Oncology, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $0 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q3 2019 $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 $0 -$341K -100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $0 -$164K -100% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $0 -$214K -100% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q3 2017 $341K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $164K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $214K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.